glp 1 agonists and sglt2 inhibitors Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classes on Mortality GLP1 Receptor Agonists vs SGLT2-I

T.StumvollM.del PratoS.et al (2019)

OZEMPIC, WEGOVY MAY BE LINKED TO STOMACH PARALYSIS AND OTHER DIGESTIVE ISSUES IN LARGE-SCALE STUDY Just as Wegovy is a higher-dose version of Ozempic to treat obesity, there is a higher-dose version of Victoza sold under the brand name Saxenda but a generic version is not yet available

13 GLP1-RAs have shown potential to reduce glycaemic variability while posing a low risk of hypoglycaemia

The product is among hundreds of dietary supplements and packaged foods trading off the nations burgeoning appetite for GLP-1 drugs, a powerful class of medications that can help with weight loss and blood sugar management

doi: 10.2337/dc15-1025 [DOI] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.

Ozempic, which is used for diabetes, costs roughly $15,000 to $16,000 per year, while Rybelsus, the oral version, also exceeds $14,000 annually (Medi-Span Price Rx, n.d.)